The Korean Journal of Pathology · 2012 · 23 citations · 28 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer Molecular DiagnosticsCancer Molecular PathologyDna SequencingMutation AnalysisPolymerase Chain ReactionThyroid CancerBraf V600 MutationsBraf V600e MutationCancer Mutation AnalysisPapillary Thyroid Carcinoma PathologyPoint Mutation AnalysisThyroid Cancer GeneticsThyroid Cancer Pathology
BACKGROUND: Papillary thyroid carcinoma (PTC) of the thyroid is the most common endocrine malignancy. High prevalence of an activating point mutation of BRAF gene, BRAF(V600E), has been reported in PTC. We assessed the efficiency of peptide nucleic acid clamp real-time polymerase chain reaction (PNAcqPCR) for the detection of BRAF(V600E) mutation in PTC in comparison with direct sequencing (DS). METHODS: A total of 265 thyroid lesions including 200 PTCs, 5 follicular carcinomas, 60 benign lesions and 10 normal thyroid tissues were tested for BRAF(V600E) mutation by PNAcqPCR and DS. RESULTS: The sensitivity and accuracy of the PNAcqPCR method were both higher than those of DS for the detection of the BRAF(V600E) mutation. In clinical samples, 89% of PTCs harbored the BRAF(V600E) mutation, whereas 5 follicular carcinomas, 50 benign lesions and 10 normal thyroid tissues lacked the mutation. The mutation was associated with aggressive clinical behaviors as extrathyroid invasion (p=0.015), lymph node metastasis (p=0.002) and multiple tumor numbers (p=0.016) with statistical significance. CONCLUSIONS: The PNAcqPCR method is efficiently applicable for the detection of the BRAF(V600E) mutation in PTCs in a clinical setting.
28
Ian Hay, Erik J. Bergstralh, John R. Goellner et al. · PubMed · 1993 · 1.2K citations
BRAF Mutation in Papillary Thyroid Carcinoma
Yoram Cohen, Mingzhao Xing, Elizabeth Mambo et al. · JNCI Journal of the National Cancer Institute · 2003 · 924 citations · Full text
BRAF mutations in papillary carcinomas of the thyroid
Toshihiko Fukushima, Shinichi Suzuki, Miyuki Mashiko et al. · Oncogene · 2003 · 298 citations